Xeris Pharmaceuticals Inc (XERS) — Cash Flow Reinvestment Rate
Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Reinvestment Rate of 0.03x as of March 2026, reinvesting $325.00K (capex $325.00K ) from operating cash flow of $9.87 Million. Check Xeris Pharmaceuticals Inc (XERS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xeris Pharmaceuticals Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Xeris Pharmaceuticals Inc across 1 annual periods. Explore Xeris Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year capital reinvestment analysis for Xeris Pharmaceuticals Inc. For live market cap and broader valuation context, see Xeris Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $696.00K | $28.63 Million | $696.00K | — |